Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v3-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2022-09-02 | 2022-09-02 |
| Drug Identification Number | 02139529 | 02139529 |
| Brand name | SODIUM ACETATE INJECTION, USP | SODIUM ACETATE INJECTION, USP |
| Common or Proper name | SODIUM ACETATE INJECTION, USP | SODIUM ACETATE INJECTION, USP |
| Company Name | FRESENIUS KABI CANADA LTD | FRESENIUS KABI CANADA LTD |
| Ingredients | SODIUM ACETATE | SODIUM ACETATE |
| Strength(s) | 328MG | 328MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS | INTRAVENOUS INTRAVENOUS |
| Packaging size | 100 mL | 100 mL |
| ATC code | B05XA | B05XA |
| ATC description | I.V. SOLUTION ADDITIVES | I.V. SOLUTION ADDITIVES |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2022-09-01 | 2022-09-01 |
| Estimated end date | Unknown | Unknown |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | Long term supply status is currently unknown; however, we assure you we are working diligently with our plants for resolution and updates can be expected in the weeks ahead. We strongly encourage all customers to use prudent conservation measures to extend the supply as long as possible. | Long term supply status is currently unknown; however, we assure you we are working diligently with our plants for resolution and updates can be expected in the weeks ahead. We strongly encourage all customers to use prudent conservation measures to extend the supply as long as possible. |
| Health Canada comments |